Nevro to Report Second-Quarter 2024 Financial Results and Host Earnings Conference Call on August 6, 2024
Nevro to Report Second-Quarter 2024 Financial Results and Host Earnings Conference Call on August 6, 2024
REDWOOD CITY, Calif., July 9, 2024 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company delivering comprehensive, life-changing solutions for the treatment of chronic pain, today announced that it will release its financial results for the second quarter of 2024 after the market closes on Tuesday, August 6, 2024. The company will also host a conference call beginning at 1:30 p.m. PDT (4:30 p.m. EDT) to discuss its financial results.
全球醫療器械公司Nevro Corp.（NYSE:NVRO）於2024年8月6日星期二收市後發佈其2024年第二季度財務業績。公司將在下午1:30（太平洋夏令時）/下午4:30（東部夏令時）舉行電話會議，討論其財務業績。
The live webcast and replay of the conference call will be available in the Investor Relations section of the company's website at Events & Presentations. The webcast can be accessed 10 minutes prior to the conference call start time.
會議現場網絡直播和回放將在公司網站的投資者關係板塊的“活動和演示”中提供。網絡直播將在會議通話開始前的10分鐘內開放。
For those parties that do not have internet access, the conference call can be accessed by calling one of the below telephone numbers and providing conference ID 9453183:
對於那些沒有互聯網訪問權限的參會者，可以撥打以下任一電話號碼並提供會議ID9453183接入電話會議：
|
U.S. domestic participant dial-in number (toll-free): |
1-(888) 596-4144 |
|
International participant dial-in number: |
1-(646) 968-2525 |
|
美國國內參與者撥打免費電話號碼： |
1-(888) 596-4144 |
|
國際參會者電話號碼： |
1-(646) 968-2525 |
About Nevro
Nevro總部位於加利福尼亞州Redwood City，是一家全球醫療器械公司，專注於提供全面、能夠改變生活的治療方案，爲慢性疼痛的治療開創了標準。該公司創立的最初宗旨是幫助更多患有疼痛的病人，並發展出了其專有的10 kHz療法，這是一種以證據爲基礎的非藥物創新，已經在全球影響了超過115000名患者的生活。Nevro全面的HFX脊髓神經刺激 (SCS)平台包括Senza SCS系統和支持慢性軀幹和肢體疼痛及痛性糖尿病神經病變的治療的支持服務。
Headquartered in Redwood City, California, Nevro is a global medical device company focused on delivering comprehensive, life-changing solutions that continue to set the standard for enduring patient outcomes in chronic pain treatment. The company started with a simple mission to help more patients suffering from debilitating pain and developed its proprietary 10 kHz Therapy, an evidence-based, non-pharmacologic innovation that has impacted the lives of more than 100,000 patients globally. Nevro's comprehensive HFX spinal cord stimulation (SCS) platform includes the Senza SCS system and support services for the treatment of chronic pain of the trunk and limb and painful diabetic neuropathy.
Nevro總部位於加州Redwood City，是一家全球醫療器械公司，專注於提供持久的患者治療方案，爲慢性疼痛治療開創了標準。該公司的創立初衷是幫助更多身患疼痛的患者，他們開發了其專有的10 kHz療法，這是一種基於證據的非藥理學創新，已經影響了全球超過10萬例患者的生活。Nevro的全面HFX脊髓刺激（SCS）平台包括Senza SCS系統和爲軀幹和四肢慢性疼痛和疼痛性糖尿病神經病提供的支持服務。
Nevro recently added a minimally invasive treatment option for patients suffering from chronic sacroiliac joint ("SI joint") pain and now provides the most comprehensive portfolio of products in the SI joint fusion space, designed to meet the preferences of physicians and varying patient needs in order to improve outcomes and quality of life for patients.
Senza、Senza II、Senza Omnia、和HFX iQ是唯一提供Nevro專有10kHz療法的SCS系統。Nevro獨特的支持服務爲每個病人提供HFX教練支持，以促進他們的止痛旅程，爲每個醫生提供HFX雲洞察以增強患者和實踐管理。
Senza, Senza II, Senza Omnia, and HFX iQ are the only SCS systems that deliver Nevro's proprietary 10 kHz Therapy. Nevro's unique support services provide every patient with HFX Coach support throughout their pain relief journey and every physician with HFX Cloud insights for enhanced patient and practice management.
Senza、Senza II、Senza Omnia和HFX iQ是唯一提供nevros專有的10 kHz療法的SCS系統。Nevro獨特的支持服務爲每個患者提供HFX Coach支持，貫穿他們的疼痛緩解過程，併爲每個醫生提供HFX Cloud洞察力，以增強患者和實踐管理。
SENZA, SENZA II, SENZA OMNIA, OMNIA, HF10, the HF10 logo, 10 kHz Therapy, HFX, the HFX logo, HFX iQ, the HFX iQ logo, HFX Algorithm, HFX CONNECT, the HFX Connect logo, HFX ACCESS, the HFX Access logo, HFX COACH, the HFX Coach logo, HFX CLOUD, the HFX Cloud logo, RELIEF MULTIPLIED, the X logo, NEVRO, and the NEVRO logo are trademarks or registered trademarks of Nevro Corp. Patents covering Senza HFX iQ and other Nevro products are listed at Nevro.com/patents.
Senza、Senza II、Senza Omnia、Omnia、HF10、HF10徽標、10 kHz療法、HFX、HFX徽標、HFX iQ、HFX iQ徽標、HFX算法、HFX CONNECt、HFX Connect徽標、HFX ACCESS、HFX ACCESS徽標、HFX COACH、HFX COACH徽標、HFX CLOUD、HFX CLOUD徽標、RELIEF MULTIPLIED、X徽標、Nevro和nevro徽標均爲Nevro Corp的商標或註冊商標。涵蓋Senza HFX iQ和其他Nevro產品的專利列在Nevro.com/patents上。
To learn more about Nevro, connect with us on LinkedIn, X, Facebook, and Instagram.
要了解有關Nevro的更多信息，請在LinkedIn、X、Facebook和Instagram上關注我們。
Investors and Media:
Angie McCabe
Vice President, Investor Relations & Corporate Communications
[email protected]
投資者和媒體:
安吉·麥凱比
投資者關係和企業傳播副總裁
[email protected]
SOURCE Nevro Corp.
來源：Nevro公司。
譯文內容由第三人軟體翻譯。